Have a feature idea you'd love to see implemented?
Let us know!
IOBT IO Biotech Inc
Price (delayed)
$0.682
Market cap
$44.93M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.29
Enterprise value
-$33.24M
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins,
Highlights
The company's EPS rose by 48% YoY and by 5% QoQ
IO Biotech's debt has decreased by 22% YoY and by 6% QoQ
The quick ratio has dropped by 61% year-on-year and by 32% since the previous quarter
IO Biotech's equity has shrunk by 54% YoY and by 25% QoQ
Key stats
What are the main financial stats of IOBT
Market
Valuations
Earnings
Shares outstanding
65.88M
Market cap
$44.93M
Enterprise value
-$33.24M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.62
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$88.99M
EBITDA
-$88.16M
Free cash flow
-$85.66M
Per share
Balance sheet
Liquidity
EPS
-$1.29
Free cash flow per share
-$1.3
Book value per share
$1.1
Revenue per share
$0
TBVPS
$1.37
Total assets
$89.95M
Total liabilities
$17.38M
Debt
$2.02M
Equity
$72.57M
Working capital
$70.19M
Debt to equity
0.03
Current ratio
5.37
Quick ratio
4.99
Net debt/EBITDA
0.89
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-75.2%
Return on equity
-86.6%
Return on invested capital
N/A
Return on capital employed
-120.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IOBT stock price
How has the IO Biotech stock price performed over time
Intraday
-16.89%
1 week
-23.37%
1 month
-42.69%
1 year
-32.48%
YTD
-63.72%
QTD
-35.05%
Financial performance
How have IO Biotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$96.42M
Net income
-$90.34M
Gross margin
N/A
Net margin
N/A
The company's operating income fell by 15% YoY and by 3.2% QoQ
The net income has contracted by 13% YoY and by 2.7% from the previous quarter
Growth
What is IO Biotech's growth rate over time
Valuation
What is IO Biotech stock price valuation
P/E
N/A
P/B
0.62
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 48% YoY and by 5% QoQ
IO Biotech's equity has shrunk by 54% YoY and by 25% QoQ
The stock's price to book (P/B) is 31% less than its last 4 quarters average of 0.9
Efficiency
How efficient is IO Biotech business performance
The return on equity has declined by 42% year-on-year and by 24% since the previous quarter
IOBT's return on assets is down by 36% year-on-year and by 20% since the previous quarter
Dividends
What is IOBT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IOBT.
Financial health
How did IO Biotech financials performed over time
The quick ratio has dropped by 61% year-on-year and by 32% since the previous quarter
The current ratio has dropped by 59% year-on-year and by 32% since the previous quarter
IO Biotech's debt is 97% lower than its equity
IO Biotech's equity has shrunk by 54% YoY and by 25% QoQ
The debt to equity has surged by 50% since the previous quarter and by 50% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.